Nova Eye Medical Limited (ASX:EYE)
Australia flag Australia · Delayed Price · Currency is AUD
0.147
+0.002 (1.38%)
Mar 10, 2026, 11:20 AM AEST

Nova Eye Medical Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2020 - 2016
Market Capitalization
413150502746
Upgrade
Market Cap Growth
30.74%-37.91%-0.19%87.27%-41.43%-52.91%
Upgrade
Enterprise Value
413249501620
Upgrade
Last Close Price
0.140.110.220.260.180.31
Upgrade
PS Ratio
1.251.072.162.962.013.43
Upgrade
PB Ratio
2.611.652.362.170.891.30
Upgrade
P/TBV Ratio
4.382.583.523.421.161.44
Upgrade
EV/Sales Ratio
1.251.112.102.921.161.48
Upgrade
EV/FCF Ratio
-7.96-----
Upgrade
Debt / Equity Ratio
0.180.160.160.070.060.11
Upgrade
Net Debt / Equity Ratio
0.01-0.11-0.13-0.25-0.20-0.40
Upgrade
Net Debt / EBITDA Ratio
-0.040.300.470.620.774.09
Upgrade
Net Debt / FCF Ratio
-0.030.320.350.831.251.04
Upgrade
Asset Turnover
1.341.040.770.510.340.17
Upgrade
Inventory Turnover
2.802.931.610.720.710.77
Upgrade
Quick Ratio
1.181.791.801.683.054.96
Upgrade
Current Ratio
1.852.392.602.334.045.62
Upgrade
Return on Equity (ROE)
-42.35%-44.96%-39.49%-57.08%-22.81%-6.41%
Upgrade
Return on Assets (ROA)
-17.92%-19.92%-18.62%-21.98%-15.42%-3.91%
Upgrade
Return on Invested Capital (ROIC)
-44.23%-50.68%-50.09%-56.57%-42.57%-33.65%
Upgrade
Return on Capital Employed (ROCE)
-39.40%-42.10%-37.10%-48.90%-29.60%-13.30%
Upgrade
Earnings Yield
-17.02%-28.98%-17.46%-30.32%-27.83%-9.47%
Upgrade
FCF Yield
-12.62%-20.63%-16.03%-14.05%-18.02%-29.42%
Upgrade
Buyback Yield / Dilution
-23.07%-21.16%-30.89%-7.83%-0.69%-0.03%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.